Immuneering (IMRX) Short-term Investments (2021 - 2024)
Historic Short-term Investments for Immuneering (IMRX) over the last 4 years, with Q3 2024 value amounting to $5.5 million.
- Immuneering's Short-term Investments fell 8132.97% to $5.5 million in Q3 2024 from the same period last year, while for Sep 2024 it was $5.5 million, marking a year-over-year decrease of 8132.97%. This contributed to the annual value of $26.3 million for FY2023, which is 2015.36% down from last year.
- As of Q3 2024, Immuneering's Short-term Investments stood at $5.5 million, which was down 8132.97% from $5.0 million recorded in Q1 2024.
- In the past 5 years, Immuneering's Short-term Investments ranged from a high of $74.3 million in Q4 2021 and a low of $5.0 million during Q2 2023
- Its 4-year average for Short-term Investments is $31.5 million, with a median of $31.0 million in 2022.
- As far as peak fluctuations go, Immuneering's Short-term Investments crashed by 416.21% in 2022, and later crashed by 8763.11% in 2023.
- Quarter analysis of 4 years shows Immuneering's Short-term Investments stood at $74.3 million in 2021, then tumbled by 55.74% to $32.9 million in 2022, then fell by 20.15% to $26.3 million in 2023, then plummeted by 79.24% to $5.5 million in 2024.
- Its Short-term Investments stands at $5.5 million for Q3 2024, versus $5.0 million for Q1 2024 and $26.3 million for Q4 2023.